Drugs for bleeding from oesophageal varices (Formulary)

TERLIPRESSIN

Important: Therapy notes

MHRA advice: Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome (March 2023) (www.gov.uk).

Important: Formulation and dosage details

Formulation:

Solution for injection 1mg/8·5mL (Glypressin®) (s)

Dosage:

For variceal bleeding and hepatorenal syndrome off-labelby intravenous injection, 2mg followed by 1 or 2mg every 4 to 6 hours until bleeding is controlled, for up to 72 hours.

Editorial Information

Document Id: F240